Global Endowment Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Hold |
18,184
| – | – | 0.04% | 114 |
|
|
2025
Q1 | $293K | Hold |
18,184
| – | – | 0.04% | 111 |
|
|
2024
Q4 | $423K | Hold |
18,184
| – | – | 0.05% | 117 |
|
|
2024
Q3 | $535K | Hold |
18,184
| – | – | 0.05% | 107 |
|
|
2024
Q2 | $428K | Hold |
18,184
| – | – | 0.05% | 115 |
|
|
2024
Q1 | $690K | Sell |
18,184
-495,252
| -96% | -$18.8M | 0.07% | 93 |
|
|
2023
Q4 | $11M | Buy |
+513,436
| New | +$11M | 1.23% | 14 |
|